Compliance updated on Sep 10, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

OmniAb Inc

OABI ✓ COMPLIANT ☆ Track — members

NASDAQ · Healthcare · Biotechnology & Medical Research ·

USA Small Cap Analyst: BUY

Last Close

$4.07

▲ +3.04%

Market Cap $591.74M · Vol 468.07K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$591.74M

Small Cap

Div Yield

N/A

EPS Growth

+37.43%

YoY

RSI (14)

45.49

Momentum

Beta

0.60

vs Market

52W High

$5.43

24.98% below

52W Low

$1.33

207.17% above

Volume

468.07K

Avg 540.54K

P/B

1.00

Price-to-book

ROE

N/A

Return on equity

Free Float

73.81%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, OmniAb Inc (OABI) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does OABI pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-14.32%

+20.41%

+73.93%

+108.18%

YTD

+120.00%

+154.38%

-22.03%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$18.67M
Net Income	$-64,779,000.00
Revenue Growth (YoY)	+244.24%
Gross Margin	29.20%
Operating Margin	-385.56%
Net Profit Margin	-347.04%
ROE	N/A
ROA · ROIC	-21.16% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	11.26
P/B	1.00
P/FCF	N/A
EPS Growth	+37.43%
Outstanding Shares	145.39M

Technical Indicators

50-Day SMA	$3.12
200-Day SMA	$2.21
RSI (14)	45.49
Beta	0.60
52-Week High	$5.43
52-Week Low	$1.33

Volume Today	468.07K
Avg Daily Volume (30D)	540.54K
Relative Volume	0.87x
Volatility (10D)	90.45
Volatility (30D)	118.83
Free Float	73.81%

Analyst Consensus

BUY

Current Price $4.07

Mean Target $7.67

52W Low$1.33 52W High$5.43

Current

Target

$1.33 $5.43

Current Analyst target

+88.45% upside potential · 7 analysts

Identifiers

ExchangeNASDAQ

FIGIBBG011J3QM48

ISINUS68218J1034

CountryUSA

Sub-IndustryBiotechnology & Medical Research (NEC)

Earnings DateNov 2, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LONN.S Lonza Group AG -0.71% ONC BeOne Medicines AG +1.38% 068270.KS Celltrion, Inc. -1.44% ABVX Abivax SA +2.32% ABVX.PA Abivax SA +1.00%

Company Profile

OmniAb, Inc. licenses discovery research technology to pharmaceutical and biotech companies and academic institutions to enable the discovery of therapeutics. Its technology platform creates and screens diverse antibody repertoires and is designed to identify optimal antibodies and other target-binding proteins for its partners' drug development efforts. Central to the OmniAb platform, Biological Intelligence, powers the immune systems of its engineered transgenic animals to create optimized antibody candidates for human therapeutics. Its proprietary transgenic animals, including OmniRat, OmniChicken and OmniMouse are genetically modified to generate antibodies with human sequences to streamline the development of human therapeutic candidates. OmniFlic and OmniClic are fixed or common light-chain rats and chickens, designed to facilitate the discovery of bispecific antibodies. OmniTaur provides cow-inspired antibodies with unique structural characteristics for challenging targets.